Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
SLB Ltd
SLB
$72.6B
| $1.25B | 0.43% |
14,505,564
+1,850,243
| +15% | +$167M |
2013 Q2
8 quarters
|
|
27
RTX Corp
RTX
$251B
| $1.23B | 0.43% |
17,575,980
+2,496,585
| +17% | +$183M |
2013 Q2
8 quarters
|
|
28
Blackstone
BX
$85.8B
| $1.22B | 0.42% |
30,512,692
-47,989
| -0.2% | -$1.97M |
2013 Q2
8 quarters
|
|
29
Starbucks
SBUX
$103B
| $1.19B | 0.41% |
22,227,331
+420,857
| +2% | +$21.4M |
2013 Q2
8 quarters
|
|
30
Williams Companies
WMB
$88.9B
| $1.19B | 0.41% |
20,687,710
-104,797
| -0.5% | -$5.4M |
2013 Q2
8 quarters
|
|
31
Philip Morris
PM
$314B
| $1.17B | 0.41% |
14,601,219
-1,669,047
| -10% | -$137M |
2013 Q2
8 quarters
|
|
32
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
| $1.15B | 0.4% |
15,517,151
-188,008
| -1% | -$13.9M |
2013 Q2
8 quarters
|
|
|
LNKD
33
DELISTED
LinkedIn Corporation
LNKD
| $1.15B | 0.4% |
5,560,253
+860,203
| +18% | +$192M |
2013 Q2
8 quarters
|
|
|
VMRK
34
Vivmark Residential
VMRK
$47.3B
| $1.14B | 0.4% |
16,291,328
+495,837
| +3% | +$36.8M |
2013 Q2
8 quarters
|
|
35
Pfizer
PFE
$161B
| $1.14B | 0.4% |
35,887,864
-1,154,640
| -3% | -$37.6M |
2013 Q2
8 quarters
|
|
|
TWTR
36
DELISTED
Twitter, Inc.
TWTR
| $1.11B | 0.39% |
30,736,405
+329,763
| +1% | +$13.5M |
2013 Q4
6 quarters
|
|
37
Tesla
TSLA
$1.51T
| $1.11B | 0.38% |
61,878,090
-6,293,595
| -9% | -$99.5M |
2013 Q2
8 quarters
|
|
38
iShares S&P 500 Growth ETF
IVW
$79.9B
| $1.07B | 0.37% |
37,621,516
-4,406,888
| -10% | -$128M |
2013 Q2
8 quarters
|
|
39
Mastercard
MA
$516B
| $1.04B | 0.36% |
11,156,292
-602,655
| -5% | -$55.3M |
2013 Q2
8 quarters
|
|
40
iShares MSCI EAFE ETF
EFA
$76.4B
| $1.04B | 0.36% |
16,422,570
+4,134,217
| +34% | +$275M |
2013 Q2
8 quarters
|
|
41
Amgen
AMGN
$224B
| $1.04B | 0.36% |
6,754,122
+483,825
| +8% | +$77.5M |
2013 Q2
8 quarters
|
|
42
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $1.03B | 0.36% |
25,207,922
+1,267,072
| +5% | +$54.4M |
2013 Q2
8 quarters
|
|
43
State Street Financial Select Sector SPDR ETF
XLF
$51.2B
| $1.02B | 0.35% |
47,497,535
+13,160,625
| +38% | +$284M |
2013 Q2
8 quarters
|
|
|
TWX
44
DELISTED
Time Warner Inc
TWX
| $1B | 0.35% |
11,488,386
-1,146,658
| -9% | -$97.9M |
2013 Q2
8 quarters
|
|
45
Invesco QQQ Trust
QQQ
$507B
| $998M | 0.35% |
9,321,254
+339,893
| +4% | +$37M |
2013 Q2
8 quarters
|
|
46
Vanguard FTSE Europe ETF
VGK
$29.2B
| $997M | 0.35% |
18,478,316
+2,440,878
| +15% | +$138M |
2013 Q2
8 quarters
|
|
47
CVS Health
CVS
$110B
| $975M | 0.34% |
9,295,398
-329,527
| -3% | -$33.7M |
2013 Q2
8 quarters
|
|
48
Blackrock
BLK
$168B
| $969M | 0.34% |
2,801,082
+245,603
| +10% | +$89.5M |
2013 Q2
8 quarters
|
|
49
AT&T
T
$152B
| $968M | 0.34% |
36,071,558
-602,888
| -2% | -$15.6M |
2013 Q2
8 quarters
|
|
50
ExxonMobil
XOM
$695B
| $961M | 0.33% |
11,552,389
-291,362
| -2% | -$25M |
2013 Q2
8 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.